Literature DB >> 15197792

Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, Pennsylvania.

Gordon F Schwartz1, Gabriel N Hortobagyi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15197792     DOI： 10.1002/cncr.20298

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  23 in total

1.  Image Registration for Microwave Tomography of the Breast Using Priors From Nonsimultaneous Previous Magnetic Resonance Images.

Authors:  Gregory Boverman; Cynthia E L Davis; Shireen D Geimer; Paul M Meaney
Journal:  IEEE J Electromagn RF Microw Med Biol       Date:  2017-12-27

2.  African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women.

Authors:  Ani Balmanoukian; Zhe Zhang; Stacie Jeter; Shannon Slater; Deborah K Armstrong; Leisha A Emens; John H Fetting; Antonio C Wolff; Nancy E Davidson; Lisa Jacobs; Julie Lange; Theodore N Tsangaris; Richard Zellars; Edward Gabrielson; Vered Stearns
Journal:  J Clin Oncol       Date:  2009-06-29       Impact factor: 44.544

3.  Locoregional therapy of locally advanced breast cancer: a clinical practice guideline.

Authors:  M Brackstone; G G Fletcher; I S Dayes; Y Madarnas; S K SenGupta; S Verma
Journal:  Curr Oncol       Date:  2015-03       Impact factor: 3.677

4.  Multiplexed quantitative analysis of CD3, CD8, and CD20 predicts response to neoadjuvant chemotherapy in breast cancer.

Authors:  Jason R Brown; Hallie Wimberly; Donald R Lannin; Christian Nixon; David L Rimm; Veerle Bossuyt
Journal:  Clin Cancer Res       Date:  2014-09-25       Impact factor: 12.531

5.  Correlation between clinical nodal status and sentinel lymph node biopsy false negative rate after neoadjuvant chemotherapy.

Authors:  Maiko Takahashi; Hiromitsu Jinno; Tetsu Hayashida; Michio Sakata; Keiko Asakura; Yuko Kitagawa
Journal:  World J Surg       Date:  2012-12       Impact factor: 3.352

6.  Intra-arterial interventional therapy for inoperable local advanced breast cancer: A retrospective study.

Authors:  Jing Ma; Jin Song; Hai Chen; Cibo Fan; Jiaqi Xie; Xiaodong Qi
Journal:  Oncol Lett       Date:  2017-11-30       Impact factor: 2.967

7.  Impact of neoadjuvant chemotherapy on breast reconstruction.

Authors:  Yue-Yung Hu; Christine M Weeks; Haejin In; Christopher M Dodgion; Mehra Golshan; Yoon S Chun; Michael J Hassett; Katherine A Corso; Xiangmei Gu; Stuart R Lipsitz; Caprice C Greenberg
Journal:  Cancer       Date:  2011-01-24       Impact factor: 6.860

8.  Primary systemic therapy with intermittent weekly paclitaxel plus gemcitabine in patients with stage II and III breast cancer: a phase II trial.

Authors:  Keun Seok Lee; Jungsil Ro; Eun Sook Lee; Han Sung Kang; Seok Won Kim; Byung-Ho Nam; Youngmee Kwon; Eun-A Kim; Kyung Hwan Shin
Journal:  Invest New Drugs       Date:  2009-02-20       Impact factor: 3.850

9.  Genetic counseling and clinical management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations: perspective of a surgical oncologist.

Authors:  Edibaldo Silva
Journal:  Fam Cancer       Date:  2007-10-18       Impact factor: 2.375

10.  Anti-Phosphohistone H3-Positive Mitoses Are Linked to Pathological Response in Neoadjuvantly Treated Breast Cancer.

Authors:  Sylvia Timme; Martin Sillem; Peter Bronsert; Lioudmila Bogatyreva; Dieter Hauschke; Axel Zur Hausen; Martin Werner; Elmar Stickeler
Journal:  Breast Care (Basel)       Date:  2017-08-02       Impact factor: 2.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.